Delivery Order SPE2DR25D2014-SPE2DR26FZ93L
Award Date 12/10/25
Potential Completion Date 12/11/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $87,963.69 and an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $13,012.76 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for supply of RINVOQ ER 15 mg tablets in quantities of 30-unit bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $15,435.05 and is scheduled for completion by November 4, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically supporting military and veteran...
- The Defense Logistics Agency awarded a $7,635.64 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $15,983.15. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 4, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) at a ceiling value of $3,279.20. This firm fixed-price, non-set-aside delivery order represents a competitive procurement action with an ultimate completion date of December 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract valued at $26,653.57, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, specifically supporting the Defense Logistics Agency's medical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $29,112.52. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for completion by December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $24,528.85 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30, with completion expected by December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and regularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units) under a firm fixed-price contract valued at $15,357.41. This non-set-aside delivery order, with an ultimate completion date of September 30, 2025, represents a procurement of pharmaceutical products to support federal medical supply requirements. The order will be performed at AmerisourceBergen's corporate office location in...